[ad_1]
The Covid-19 vaccine will have a significant effect during the summer of 2021, notably leading to a “drastic reduction in cases” of infection. But only in next year’s winter is life should go back to normal – what was it before the pandemic. The forecasts come from Uğur Şahin, the Turkish scientist who created BioNTech, who, in early November, announced to the world, together with the pharmaceutical company Pfizer, that his vaccine candidate was more than 90% effective in preventing Covid-19. .
I am very confident that human-to-human transmission will be reduced with an effective vaccine, not by 90%, but perhaps by 50%, but we must not forget that even this can result in a drastic reduction in the spread of the pandemicHe said in an interview with the BBC.
Scientist Uğur Şahin said that if all goes according to plan, the vaccine should start shipping at the end of this year, early next year. The objective, he explains, is to deliver more than 300 million doses worldwide Until April 2021 – that will give 150 million people since the vaccine must be given in two doses.
6 clues to understand the importance of the Pfizer vaccine, which is 90% effective against Covid
This distribution until April 2021 “could let you start having an impact “ in the world, believes the scientist. However, the impact will only begin to be felt later.
Summer will help us because the contagion rate will drop in the summer and what is absolutely essential is that we have a high vaccination rate until or before the fall / winter of next year, “he said.
Uğur Şahin also added that the “main side effects” of the vaccine detected so far have been mild to moderate pain at the injection site for a few days, although some volunteers have had mild to moderate fever for a similar period. “We did not detect any other serious side effects that would result in the study being stopped or interrupted, ”he added.
The European Union has already bought 200 million doses (giving 100 million people) and this reserve will also serve Portugal. The general director of Health, Graça Freitas, confirmed that this vaccine “is one of those that the country plans to acquire.”
